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Abstract
Background: The Ministry of Health (MOH) launched the National Reproductive Health Policy in 2005, which
included recommendations regarding the use of emergency contraceptive pills (ECP). However, ECP have not yet
been introduced officially in the public sector of the Lao PDR. Thus, their availability is limited. Understanding the
knowledge of ECP and attitudes about their provision, barriers to use, and availability among health providers and
policy makers is essential to successfully incorporate ECP into reproductive health services.
Methods: Qualitative research methods using in-depth interviews were employed to collect data from policy
makers and health providers (auxiliary medical staff, nurses, and medical doctors). Altogether, 10 policy makers, 22
public providers, and 10 providers at private clinics were interviewed. Content analysis was applied to analyze the
transcribed data.
Results: The majority of policy makers and health care providers had heard about ECP and supported their
introduction in the public sector. However, their knowledge was poor, many expressed inconsistent attitudes, and
their ability to meet the demand of potential users is limited.
Conclusions: There is a need to train health providers and policy makers on emergency contraception and
improve their knowledge about ECP, especially regarding the correct timing of use and the availability of methods.
In addition, the general public must be informed of the attributes, side effects, and availability of ECP, and policy
makers must facilitate the approval of ECP by the Lao Food and Drug Administration. These interventions could
lead to increased access to and demand for ECP.
Background
The Lao PDR is a low income country with an esti-
mated population of only 5.6 million. The country is
divided into 17 provinces and is ethnically and linguisti-
cally diverse, and geographically widespread (49 ethnic
groups and 20 inhabitants per square km). The coun-
try’s fertility rate is high (4.07), ranging from 2.04 for
urban women to 4.74 for rural women. The maternal
mortality rate is also high at 405/100,000 live births.
The life expectancy at birth is 63 and the under-five
mortality rate is 68 per 1,000 live births. The contracep-
tive prevalence rate is 38.4% (35% using modern meth-
ods and 3.4% using traditional methods). The most
popular method currently used for married women is
the oral contraceptive pill (16%), followed by injectable
contraceptives (10.6%) [1,2].
To help alleviate the unmet need for contraception
(the average desired family size was 4.2 for the period
1990-1995), the Ministry of Health (MOH) launched an
official Birth Spacing Program with support of the
UNFPA in 1993 and began its nationwide implementa-
tion in 1996. Government partners included family plan-
ning and selected reproductive health service workers
who were provided with training on how to disseminate
reproductive health and family planning information at
the community level [3]. This program was the respon-
sibility of the Mother and Child Health Center (MCH)
under the name “Reproductive Health Project”.D e s p i t e
its implementation, only a few methods of contraception
are routinely offered in hospitals and MCH clinics at
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sterilization (at provincial hospitals only), depo
medroxy-progesterone acetate (DMPA), condoms and
oral contraceptives (OC). Oral contraceptives and con-
doms are also available at the village level through mass
organizations and from village health volunteers or com-
mittee leaders who have received basic training. Con-
doms and oral contraceptive pills are provided free in
the public health care sector. Some other forms of con-
traception such as vasectomy are discussed by public
sector providers, but not commonly used by the popula-
tion because of low levels of acceptability. Other meth-
ods such as implants, female condoms, diaphragms, and
emergency contraceptive pills (ECP) have not yet been
implemented in the public sector and but are available
in some private clinics.
Recently, the MOH (2005) [3] endorsed a National
Reproductive Health Policy which included emergency
contraceptive pills (ECP) as a family planning compo-
nent. The policy aimed to promote information about
emergency contraception and to ensure the availability
of the method at specified government health facilities.
However, there are currently no suppliers of ECP
within the country, and these drugs are not officially
registered by the Food and Drug Administration (FDA)
which is a prerequisite for the drug to be officially dis-
tributed in the public sector. At present, no pharma-
ceutical company in Lao PDR is marketing emergency
contraceptives. This may be due to poor levels of
knowledge regarding emergency contraceptives among
people in the medical community and lack motivation
for the required effort of getting the drugs registered.
The next step needed to be taken for ECPs drugs to
get registered is to identify partners to register the
ECP products and conduct advocacy with the relevant
authorities. However, there are some dedicated emer-
gency contraceptive products sold at some private
pharmacies and clinics because they are brought into
the country illegally. Some providers prescribe women
a higher dosage of the regular combined oral contra-
ceptive pills, which can be taken as emergency contra-
ception. However, this is not a very common practice
because the clients do not understand these hormonal
pills and many providers know very little about emer-
gency contraception.
Emergency contraceptives (EC) are used to prevent
unwanted pregnancy. There are several methods of
emergency contraception, such as IUD insertion or hor-
monal ECP which could be either of a) combined hor-
monal contraceptives, b) levonorgestrel only in one or
two doses (1.5 mg) and finally c) Ulipristalacelat 30 mg
[4]. IUDs can be used as an EC method by inserting the
IUD within 5 days of unprotected sex. The mechanism
of ECP is mainly through inhibiting ovulation.
T h ep u b l i ch e a l t hc a r es y s t e mi nL a o sc o n s i s t so f
three levels: central, provincial, and district. At the cen-
tral level, the Ministry of Health (MOH) is in charge of
the National Institute of Public Health, the University of
Health Sciences, the Central Pharmaceutical Enterprise,
the central hospitals; and nine centers, including the
Maternal and Child Health Center (MCH). The MCH
centers’ primary responsibilities include formulating
maternal and child health policies and programs, and
coordinating the nationwide provision of maternal and
child health services. This includes prioritizing interven-
tions; monitoring progress towards targets; and coordi-
nating national, NGO and donor activities in maternal
and child health [5]. At the provincial level, services are
coordinated by the provincial health office and include
service provision through provincial hospitals (45-240
beds) and supervising/supporting district health offices.
The provincial health system is mirrored at the district
level, where the district health office oversees services
provided at the district hospitals and supports service
delivery at the health post or dispensary level. District
hospitals have between 15-25 beds and provide care for
a population of about 300,000 people. In addition, there
are health volunteers in each village who focus on health
education, communication, hygiene, and disease preven-
tion [5].
In addition to public health facilities, there are more
than 900 private clinics in the country, most of which
are located in the capital, Vientiane, and almost 2,000
registered pharmacies, located mostly in urban areas in
close proximity to district or provincial hospitals. The
private clinics and pharmacies play an important role in
providing accessible sexual reproductive health services
in urban areas and help improve quality of health care
through their resources, expertise, and infrastructure [5].
In the Lao PDR, abortion is illegal and highly
restricted; the vast majority of procedures are clandes-
tine and a high proportion is unsafe. Legal abortion is
permitted only to save the life of pregnant women; how-
ever, there are no clear criteria established regarding
indications for termination of pregnancy and there is
very limited data on the actual use of abortion. Clandes-
tine abortions are commonly performed under unsani-
tary conditions by unskilled practitioners using
dangerous techniques [5].
Service providers and other health care personnel can
play an important role in ensuring the availability and
use of EC. Providers’ attitudes may also play an impor-
tant role in introducing EC. However, there are a num-
ber of potential barriers to providers introducing EC in
any country, including Laos. The first is the erroneous
perception that the method is abortifacient. A second
barrier pertains to conservative attitudes towards sexual-
ity. Physicians may be reluctant to offer EC in Laos, as
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continued ignorance of the available methods among a
large proportion of the health care providers [6]. A final
barrier in Laos is legal, because the drug has not yet
been registered by the Lao FDA.
This study aims to explore the knowledge of ECP and
attitudes about provision of ECP among policy makers
and health providers in both the public and private sec-
tor. Information gained from this study will inform pol-
icy makers about the necessary interventions to increase
access to and demand for ECP, including: (1) increasing
knowledge of ECP among health providers and policy
makers, (2) increasing knowledge of ECP among the
public, and (3) encouraging approval of ECP by the Lao
Food and Drug Administration.
Methods
Study setting
The study was carried out in Vientiane, the capital of
the Lao PDR, between March and June of 2007. Vien-
tiane has a population of 700,000 and has the highest
population density in the country. Compared with other
parts of the country, the capital city has both higher
levels of education and income, and is the center of cul-
ture, commerce and administration in Laos. There are
108 private clinics in Vientiane, of which 82 provide
sexual reproductive health services. The prevalence of
contraceptive use in Vientiane is 61 percent [7].
A rapidly changing economy has an impact upon the
sexuality of young people: high levels of internal migra-
tion place many young people far away from their vil-
lages and cultural norms, with an increased risk of
unprotected sexual relations.
Study participants
The target groups of this study were policy makers,
health providers, and staff of public and private clinics.
Policy makers were selected from the Ministry of
Health, and included the director of the Preventive and
Curative Department, the director of the FDA, the
director of the Maternal and Child Health Center
(MCH), and directors from six central hospitals. Public
health providers were medical doctors and nurses work-
ing in family planning services, including obstetric-
gynaecology wards in the government sectors. Private
providers were chosen from those who provide Sexual
Reproductive Health (SRH) services. The participants
were selected to reflect the public and private sectors as
well as SRH professional backgrounds.
Data Collection
The first author (VS) initially contacted the key infor-
mants through colleagues in the Ministry of Health,
central hospitals, and private clinics. In-depth interviews
were carried out face-to-face with the key informants -
10 policy makers, 22 public providers (12 medical doc-
tors and 10 nurses), and 10 health providers at private
clinics. Participants were interviewed in private offices at
the Ministry of Health, hospitals, and private clinics by
the trained interviewers. The interviewers were from the
Faculty of Postgraduate Studies and Research who had
medical backgrounds. The objectives of the in-depth
interviews were to assess the perception and attitudes
towards ECP and to understand the beliefs and experi-
ences in communicating with clients. Guidelines for the
in-depth interviews were prepared both in English and
Lao (Appendix 1), and the information obtained was
fully transcribed from tape recordings for analysis.
The material from the interviews was organized and
coded based on a content analysis. The latent analysis is
denoted as interpretation of underlying meaning of the
text and deals with the relationship aspect, while the
manifest deals with the visible and obvious components
[8]. The manifest analysis was used in this study. The
texts from transcription of the in-depth interviews were
read several times to comprehend the material in its
entirety. The meaningful units were condensed to
shorten the text without losing the message. Next, the
condensed meanings were labeled with an open code
representing content; then, open codes were compared
to investigate differences and similarities, and create
categories. Finally, the categories were compared to
identify sub-themes and themes.
The major themes were knowledge of ECP and atti-
tudes related to the provision of ECP. Table 1 gives an
example of the analysis process. The first interview was
coded together by four members of the study team to
develop mutually agreed upon definitions for each code
and to establish examples of each code; codes were then
reviewed and revised. Each interview was then coded
separately by two members of the study team. After
coding, the two team members met to discuss the
results; again, any disagreements in coding were
resolved by consensus. Categories and themes were
arrived at by consensus between the four authors.
Ethical clearance was obtained from the National Ethi-
cal Review Board, Ministry of Health, and the Ethical
Review Board at the University of Health Sciences. Ver-
bal informed consent was obtained from each partici-
pant. All information gained from the study participants
was confidential and participants could withdraw their
participation anytime during the interview. Pseudon-
ymous were used to ensure anonymity.
Results
The majority of key informants were male (7 males in
10 policy makers, 13 in 22 public providers; 6 in 10 pri-
vate clinics). Among the policy makers, three were from
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from the Mother and Child Health Center, one was
from the military hospital, and one was from the police
hospital. Policy makers were the directors of the depart-
ments of the MOH and the hospitals. Ten of public pro-
viders were medical doctors and twelve were nurses who
worked in the gynaecology-obstetric wards and mother
and child units that provided sexual reproductive health
services. The ten private care providers worked in obste-
trics-gynaecology and family planning programs in the
public sector and operated their clinics after working
hours in the government sector. Nearly two-thirds of
key informants had at least nine years of working
experiences.
Limited knowledge, confusion and misconceptions of ECP
Most public health care providers and private clinicians
were familiar with the term ‘Emergency Contraception
Pills’ but lacked detailed technical knowledge. Some
could cite examples of emergency pills.
“I heard about ECP from our staff, but I do not know
the mechanism of action in detail.” (Female public
health provider, 55 years old)
“I heard about ECP before from my colleague who
opened a private clinic - brands such as Postinor,
Madonna - and that these drugs should be taken
within 12 hours after having intercourse and that
there are some effects on hormones that affect the
Table 1 Summary of themes, categories and codes form analysis
Codes Categories Themes
Heard of ECP Understanding of ECP Limited knowledge, confusion and misconceptions of ECP
Lack of knowledge of mechanism
Lack of knowledge of dosing
Lack of knowledge of timing
Lack of knowledge of side effects
Confusion the different names of ECP
Training Source of information
Media
Study tours
Maternal & Child Health Center
Colleagues
Prescription
Agree to provide ECP versus disagree Access to ECP services Ambivalent atttitudes, hesitations towards increased access to
ECP
Back up method
Young people Target population
Rape victim
Married couples with occasional sexual intercourse
Everybody
Health care provider Distribution channels
Media
Maternal and Child
Obstetric-gynaecological wards
FDA
Positive effect Effect of Availability of
ECP
ECP encourage unsafe sexual behaviors
Negative effect
Outweigh of positive effect than negative effect
No registered drugs Lack of information Barriers of use ECP
Clandestine drugs
No drug supplier
Lack of awareness of policy
Shy and embarrassment Cultural values
Negative attitudes towards premarital sex and
abortion
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health provider, 37 years old)
There were some misconceptions and confusion about
the different brand names of ECP and the corresponding
time that each drug should be taken. There was also
confusion about the purpose of each drug. Many provi-
ders stated that ‘ECP’, ‘post-coital pills’ and ‘after morn-
ing pills’ are different in terms of frequency, dosage,
effectiveness, and composition. As two key informants
mentioned:
“The terms ‘ECP’, ‘post coital,’ and ‘morningafter
pills’ are the same, but the difference is the time that
patients taken the medicine. The term ‘morning after
pills’ means that pills cannot be taken until the
morning and ‘post coital’ indicates that they should
be used immediately after sex.” (Male private provi-
der, 40 years old)
“’ECP’ should be taken about 5 hours after having
sexual intercourse; while ‘morning pills’ should be
t a k e ni nt h em o r n i n ga n dt h e i re f f e c ti ss l o w . ”
(Female public provider, 45 years old)
Moreover, the interval between the repeated doses
reported by respondents varied from six hours to 12
hours and the time limit for starting the regimen varied
from one hour to 72 hours following unprotected sex.
“I think that the first pill of Postinor is taken about 6
hours after having sexual intercourse.” (Female public
provider, 40 years old)
Among those who knew about ECP, the knowledge
they reported generally concerned the dosing schedule,
timing, side effects, and mechanism(s) of action, but
the provider’s supposed “knowledge” was often not
accurate. Many erroneously believed that repeated use
posed health risks such as breast and ovarian cancer.
Few public and private clinics correctly identified nau-
sea and vomiting as possible side effects, and few of
them knew that the method worked by inhibiting
ovulation.
Most respondents obtained their information from
training courses, colleagues, and private providers.
Other sources of information were journals, internet
pages, formal training and visits to Maternal and Child
Health Centers (MCH) in Thailand. The majority of
health care providers had never prescribed ECP because
their clients did not demand it from them and there
was no supply.
“Il e a r n e da b o u tE C Pw h e nIw a st r a i n e di na n
obstetric-gynaecology residency program. After I
finished the residency program, I did not prescribe
E C Pt oc l i e n t sb e c a u s eIw a sn e v e ra s k e dt od os o . ”
(Female public health provider, 35 years old)
“No doctors prescribe it in the hospital, so midwives
do not know it well.” (Nurse, 35 years old)
Ambivalent attitudes and hesitation regarding increased
access to ECP
Access
The attitudes of health providers towards ECP are
ambivalent. The majority of both policy makers and
providers had positive attitudes towards ECP and agreed
that ECP should be introduced into the public sector.
However, some of them expressed conservative attitudes
towards ECP.
“I do not agree with introducing ECP in the public
sector because it will encourage young people to have
more casual sex. So we need to tell the potential
users that ECP could be used to prevent unwanted
pregnancy, but not prevent STIs.” (Male public health
provider, 36 years old)
These providers will advise potential users that ECP
are an emergency choice only, that they should be used
in an emergency situation or as a back up method to
prevent an unwanted pregnancy, and that the drugs
should not be used regularly. However, they will explain
how to use the drug and inform the user about side
effects. As a key informant explained:
“Emergency contraception needs to be reserved for
emergency situations and it should not be used as a
substitute for regular contraception.” (Male public
health provider, 30 years old)
Target population
Some health providers feel a need to limit the use of
these drugs among young people because of the fre-
quency of unsafe and unplanned sex within this group.
Some health providers want to limit the use of the
drugs only for rape victims. Many believe that unmar-
ried youth should not use ECP. If ECP are too conveni-
ent to access, youth would forget to use condoms.
Promiscuity, premarital sex, and the incidence of STIs
would then increase. Other providers would like to
restrict the use of the drugs to married couples; only a
few providers felt that everybody should have access to
the use of ECP.
“Emergency contraception can be used when one
partner works away from home and the couple does
not live together, or for people who only occasionally
have sex.” (Male private provider, 50 years old)
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The majority of policy makers and health providers
thought ECP were an essential component of contracep-
tive services but preferred distribution through health
care providers only. Maternal and Child Health Center
(MCH) and the obstetric-gynaecological wards at public
health facilities providing family planning services to
women were thought to be the most suitable. ECP
could be easily integrated into existing services because
these institutions already provide contraceptives.
“The MCH and obstetrics-gynaecology sections should
be responsible for introducing ECP into the services of
family planning because they are responsible for
reproductive health care and family planning servi-
ces."(Male private provider, 45 years old)
“The MCH center should be responsible for the provi-
sion of ECP under supervision of the Department of
Health Prevention, Ministry of Health.” (Female pol-
icy maker, 56 years old)
Some mentioned that pharmacies should not provide
ECP. According to this view, the demand for ECP
would increase if they were available by this route, caus-
ing potential users to rely on ECP over more effective,
ongoing methods. It was assumed that such a scenario
would encourage more casual sex and the incorrect use
of ECP.
“If pharmacies sell ECP, users will use it at will,
similar to the Chinese drug ‘Ya Chine’ (an abortifi-
ciant drug), and there will be some negative conse-
q u e n c e sa sar e s u l to fw i d e s p r e a du s eo fE C P . ”
(Female public health provider, 35 years old)
Barriers to Use
Most key informants, both policy makers and health
care providers, mentioned that ECP are not yet regis-
tered through the FDA and are therefore clandestine
drugs. There is currently no supplier of ECP to the
country. A major barrier to the demand for ECP is lack
of information, as ECP is never mentioned in the mass
media.
“Potential users don’t know the drug because it is not
widely used within the country and they do not know
where they can get it.” (Male policy maker, 50 years
old)
Nearly all policy makers and health providers are
aware that there is a political barrier from policy makers
at the Ministry of Health. The Ministry does not cur-
rently allow the legal use of ECP in the Lao PDR, how-
ever, some policy makers and providers interviewed in
this study were not aware of this policy. A few health
providers cited that the barriers to ECP were conserva-
tive and strict cultural values and norms towards pre-
marital sex and abortion. Other potential barriers are
shyness and embarrassment about purchasing the drugs,
especially for young people.
Availability
Overall, most interviewees predicted more positive than
negative effects from easier access to ECP. One positive
effect is to prevent unwanted and unplanned pregnan-
cies, especially in the case of rape. In addition, it was
believed that the incidence of induced abortion would
be reduced, and complications stemming from induced
abortions- such as tubal infections, bleeding, perforation
of uterus - would be reduced. These policy makers and
providers foresee no adverse effect of the use of ECP on
STIs. Because health staff provide health education
about STIs, it is unlikely that the availability of ECP will
increase casual sex and promiscuity and reduce the like-
lihood of using condoms for dual protection against
HIV and STIs.
In contrast to the optimists described above, some
policy makers and health care providers hinted, though
to varying degrees, towards the negative effects of the
general availability of ECP, mentioning increased pro-
miscuity and STIs. As one key informant said:
“I think that people will have more casual sex and
STIs will increase because the clients are more afraid
of becoming pregnant than getting STIs.” (Male policy
maker, 47 years old)
However, few policy makers expect that routine con-
traceptive use will decrease. Most of the key informants
are convinced that the positive effects outweighed the
negative effects.
“There would be more positive effects from the avail-
ability of ECP than negative effects. For example, the
number of unwanted pregnancies would be reduced
and the number of newborns without fathers also
would be reduced. Still, there could be some negative
effects, such as an increase in unplanned sex and
STIs.” (Male policy maker, 55 years old)
Discussion
This study indicated that both public and private provi-
ders are ignorant about the effect and mechanism of
action, side effects, indications, and effectiveness of ECP.
This corresponds with results from studies conducted
elsewhere indicating that the knowledge of health provi-
ders on EC is low [9-14]. Most believe that repeated use
poses a health risk. Although the available evidence indi-
cates that repeated use is safe [15,16], this is not
acknowledged by health professionals in a wide range of
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that some health providers are reluctant to provide the
pills on multiple occasions.
Most providers have ambivalent attitudes. They agree
that ECP should be introduced in the public sector, but
they want to limit its use to married couples. As in
other studies carried out elsewhere, providers are less
positive about EC use by adolescents [13]. Both public
and private providers also expressed concern that
increased access to the method could encourage unpro-
tected sexual intercourse or reduce routine contracep-
tive use. However research in a variety of contexts has
shown that expanded access does not increase the rate
of unprotected sexual intercourse, nor does it change
sexual behaviour [20,21]. Other studies found that
advanced provision of ECP does not appear to adversely
affect use of regular contraception or encourage
repeated use of emergency contraception [22-24].
Health providers will play an important role in provid-
ing health education on ECP and distributing the medi-
c a t i o no n c ei ti sa p p r o v e db yt h eF D A .H o w e v e r ,w i t h
the current low levels of knowledge and with ambivalent
attitudes, these providers can not be relied upon to give
accurate and consistent advice to potential clients. Thus,
health providers must be educated on all salient aspects
of the drugs, including the dosing schedule, timing, side
effects, and mechanism(s) of action. Only with accurate
information will policy makers be an asset in public
health education and advocacy.
Women experience multiple barriers when attempting
to access emergency contraception. The main barriers
for potential use include widespread lack of knowledge
about ECP among women and providers, lack of avail-
ability [25], and shyness and embarrassment to obtain
t h ed r u g s .I nI t a l y ,w h e r ep e o p l ea r ea l s op o o r l y
informed on the available methods, it was found that
this was a major obstacle for the more widespread use
of emergency contraception [26]. As a consequence of
lack of commercial promotion of ECP, very few women
know that emergency contraception is available, effec-
tive, and safe [27]. Thus, there is a pressing need for a
social marketing campaign to educate the general public
about ECP and to update them on the approval process
of the drugs.
Emergency contraception is not universally available in
Laos because these drugs are not registered officially
with the FDA; however, they are available at private
drugstores (brands such as Postinor and Madonna). The
MOH included ECP in its National Reproductive Health
Policy in 2005 and MCH centers will be responsible for
the provision of ECP. However, because ECP have not
yet been approved by the FDA, policy makers need to
advocate for and assist in obtaining approval. Approval
would facilitate access to and demand for ECP where
women have access to government public health facil-
ities. In addition, providers would be more inclined to
provide ECP if they was approved by the FDA [6].
Methodological Considerations
This study applied a qualitative design to explore the
perceptions of policy makers and providers on ECP,
using in-depth interviews as the major tool. More focus
group discussions or a triangulation of methods might
have better highlighted this issue. It should be noted
that the pharmacist’sa n dc l i e n t s ’ perspectives and
experiences were not taken into account, and we
acknowledge the need to explore this to capture the full
picture of the provision of ECP.
Preconceptions of the interviewers, most of whom had
medical backgrounds, may have affected the interpreta-
tion of data gained from the interviews. To control for
this, group checking with the research team and profes-
sional colleagues was done after data collection to assess
the trustworthiness of the interpretation of the data.
As for qualitative studies in general, our findings can-
not be transferred directly to other settings. However,
the study can give valuable insights to other researchers
working in similar settings. The key informants were
selected based on the diversity of the perspectives they
could bring to ECP in the urban areas, but not in the
rural areas; furthermore, rural health providers’ knowl-
edge and attitudes related to ECP should be considered
in additional studies of the issue.
Conclusion
This is the first study on knowledge and attitudes of
ECP within the public and private sectors of the Lao
PDR. Awareness about ECP among providers and policy
makers is low, and knowledge about ECP among health
providers is inadequate. In order to introduce ECP into
the public and private sector, there is a need to imple-
ment an educational campaign. Educational efforts
should focus on the training of health care providers
with regards to the available methods and correct timing
of use. The standard guidelines for EC use should reflect
those of the World Health Organization and other inter-
national organizations. The key messages should empha-
size effect, indication, side effects, and dosage (two-
tablet doses). In addition, to confirm the legal status of
ECP, they should be approved by the FDA. At the popu-
lation level, efforts need to be made to educate the
population about ECP. The information should include
the nature of side effects, the emergency contraceptive
pill regimen, and the mechanism by which emergency
contraceptive pills disrupt fertilization. These measures
would greatly improve women’s access to, demand for,
and effective use of ECP. In addition, educational cam-
paigns could seek to teach women how to take regular
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becomes available.
Appendix 1: Guideline for in-depth interview
1. In your opinion, what are the differences betwen
Emergency Contraceptive Pills (ECPs), Post - coital pills
and morning after pills?
2. Have you ever studied or heard about ECPs before?
If yes, from where? What did you learn or hear? Are
there any issues on this regard that you would like to
know more? (Probe for indications of the use, side
effects...) If you have never learned or heard about ECP,
what contents that you would like to learn about? What
are the reliable source(s) of this information? Why?
3. Attitude of providers towards ECP:
￿ What is your opinion about telling potential users
about ECP as an emergency choice?
￿ In case of providing ECP for women as an emer-
gency back -up method, what is your opinion about
this idea?
4. ECP services for a wider perspective:
￿ What is your opinion towards ECP as an emer-
gency choice for women?
￿ What organizations should be involved for appro-
priate ECP use? What section in the health care
facility is suitable for integrating ECP into the ser-
vices? Why?
￿ Who should be the potential ECP providers? Why?
￿Effect from the availability of ECP towards casual
sex or/and prevention? (probe for negative and posi-
tive effect to the user)?
￿ Information dissemination to the public, what is
the critical information that should release to the
public. What do we expect public to learn about
ECP?
5 .A r et h e r ea n yE C Pa v a i l a b l ef o rw o m e na ty o u r
o r g a n i z a t i o n ?I fy e s ,w h a tt y p eo fE C P .I fn o ,w h ya r e
ECP not included in your organization?
￿ Who should be the potential users?
￿ How do you feel about women who used ECP?
Why can potential users not obtain ECP? What are
the barriers? Describe? (Probe for information and
communication, culture, values and norms, time and
transport, price...)
6. What are the appropriate means of providing infor-
mation for ECP users to strengthen the health services?
￿ For service providers what are key messages and
format?
￿Type of printed materials for ECP users. What
should it be?
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